JPRN-UMIN000003556已完成2 期
Postoperative adjuvant immunochemotherapy of tumor specific peptide vaccine plus CDDP+5FU chemotherapy for esophageal cancer patients with pathological lymph node metastasis who underwent no preoperative treatment- Multicenter Phase II trial - Postoperative adjuvant tumor specific peptide vaccine plus FP chemotherapy for pN(+) esophageal cancer patients without preoperative therapy
Kinki University Faculty of Medicine0 个研究点目标入组 60 人开始时间: 2010年5月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Infectious disease (ex. patients with high fever of 38.5 degrees C or more, et cetra) 2)Severe heart disease or past history of the disease 3)Severe postoperative complications (ileus, interstitial pneumonia, uncontrolled DM, renal failure, cirrhosis, et cetra) 4)Severe mental disorder 5)Another active malignant disease 6)Brestfeeding and pregnancy (woman of child bearing potential) 7)Man with an intention to get with child 8)Autoimmune disease 9)Retention of pericardial fluid to cause heart failure or pericarditis 10)Decision of unsuitableness by principal investigator or physician-in-charge
研究者
相似试验
已完成
2 期
Postoperative adjuvant immunotherapy of tumor specific peptide vaccine for esophageal cancer patients with pathological lymph node metastasis who underwent preoperative therapy followed by surgery- single institute exploratory Phase II trialesophageal cancerJPRN-UMIN000003557Kindai University Faculty of Medicine, Department of Surgery60
进行中（未招募）
1 期
Adjuvant immunotherapy after salvage surgery in head and neck squamous cell carcinomahigh risk recurrent head and neck squamous cell carcinoma (HNSCC)MedDRA version: 20.0Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-001277-17-FRGustave Roussy140
已完成
1 期
eoadjuvant immunochemotherapy using intratumoral injection of dendritic cells for thoracic esophageal cancersThoracic esophageal cancersJPRN-UMIN000000669Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University10
已完成
不适用
Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinomaoral squamous cell carcinomaJPRN-UMIN000033453agasaki University50
进行中（未招募）
1 期
Comparison of immunotherapy versus chemo-immunotherapy in patients with advanced gastric cancer and adenocarcinoma of esophagusHistologically confirmed, resectable advanced gastric cancer GC and adenocarcinoma of the esophago-gastric junctionMedDRA version: 21.1Level: PTClassification code 10017758Term: Gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10030151Term: Oesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000383-28-DEniversity Hospital Essen44